Palivizumab and respiratory syncytial virus immune globulin intravenous for the prophylaxis of respiratory syncytial virus infection in high risk infants
Paediatr Child Health
.
1999 Oct;4(7):474-89.
[Article in English, French]
Author
joint statement with the Fetus and Newborn Committee
PMID:
20212962
PMCID:
PMC2827759
No abstract available